References
- Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115:5005–5011.
- Baehring JM, Damek D, Martin EC, et al. Neurolymphomatosis. Neuro Oncol. 2003;5:104–115.
- Gan HK, Azad A, Cher L, et al. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol. 2010;12:212–215.
- Tomita M, Koike H, Kawagashira Y, et al. Clinicopathological features of neuropathy associated with lymphoma. Brain. 2013;136:2563–2578.
- Schmitz N, Zeynalova S, Nickelsen M, et al. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016;34:3150–3156.
- Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve. 2005;31:301–313.
- Kamiya-Matsuoka C, Shroff S, Gildersleeve K, et al. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes. J Neurol Sci. 2014;343:144–148.
- Kinoshita H, Yamakado H, Kitano T, et al. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases. J Neruol. 2016;263:19–26.
- Shaikh F, Chan AC, Awan O, et al. Diagnostic yield of FDG-PET/CT, MRI, and CSF cytology in non-biopsiable neurolymphomatosis as a heralding sign of recurrent Non-Hodgkin's Lymphoma. Cureus. 2015;7:e319.
- Choi YJ, Shin JA, Kim YH, et al. Neurolymphomatosis of brachial plexus in patients with Non-Hodgkin's Lymphoma. Case Rep Oncol Med. 2013;2013:492329.
- Yazawa S, Ohi T, Shiomi K, et al. Brachial plexus neurolymphomatosis: a discrepancy between electrophysiological and radiological findings. Intern Med. 2007;46:533–534.
- Lagarde S, Tabouret E, Matta M, et al. Primary neurolymphomatosis diagnosis and treatment: a retrospective study. J Neurol Sci. 2014;342:178–181.